Published in Bioengineered on January 17, 2013
Synergistic action of cinnamaldehyde with silver nanoparticles against spore-forming bacteria: a case for judicious use of silver nanoparticles for antibacterial applications. Int J Nanomedicine (2013) 0.87
Probiotic engineering: towards development of robust probiotic strains with enhanced functional properties and for targeted control of enteric pathogens. Gut Pathog (2017) 0.75
Foodborne illness acquired in the United States--major pathogens. Emerg Infect Dis (2011) 24.75
Quorum sensing: cell-to-cell communication in bacteria. Annu Rev Cell Dev Biol (2005) 13.88
Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science (2000) 6.19
Anti-virulence strategies to combat bacteria-mediated disease. Nat Rev Drug Discov (2010) 4.23
Food-borne diseases - the challenges of 20 years ago still persist while new ones continue to emerge. Int J Food Microbiol (2010) 3.17
Engineering microbes to sense and eradicate Pseudomonas aeruginosa, a human pathogen. Mol Syst Biol (2011) 2.59
Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol (2008) 2.58
The health burden of Campylobacter infection and the impact of antimicrobial resistance: playing chicken. Clin Infect Dis (2007) 2.00
Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology (2009) 1.96
Analysis of foodborne outbreak data reported internationally for source attribution. Int J Food Microbiol (2009) 1.95
Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat Biotechnol (1997) 1.77
Probiotics and prebiotics in animal feeding for safe food production. Int J Food Microbiol (2010) 1.62
Bacteriophage for biocontrol of foodborne pathogens: calculations and considerations. Curr Pharm Biotechnol (2010) 1.53
Gastroenterology in developing countries: issues and advances. World J Gastroenterol (2009) 1.53
Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge. Proc Natl Acad Sci U S A (2009) 1.49
Magnitude and impact of diarrheal diseases. Arch Med Res (2002) 1.49
Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7. Infect Immun (2004) 1.48
A review of vaccine research and development: human enteric infections. Vaccine (2005) 1.46
Safety assessment of probiotics for human use. Gut Microbes (2010) 1.44
Engineered bacterial communication prevents Vibrio cholerae virulence in an infant mouse model. Proc Natl Acad Sci U S A (2010) 1.39
Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea. J Infect Dis (2006) 1.31
Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus. Mucosal Immunol (2011) 1.30
Ionophores: their use as ruminant growth promotants and impact on food safety. Curr Issues Intest Microbiol (2003) 1.28
Probiotics, their health benefits and applications for developing healthier foods: a review. FEMS Microbiol Lett (2012) 1.24
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. Appl Environ Microbiol (2008) 1.23
Genetically modified Streptococcus mutans for the prevention of dental caries. Antonie Van Leeuwenhoek (2002) 1.21
Improving gastric transit, gastrointestinal persistence and therapeutic efficacy of the probiotic strain Bifidobacterium breve UCC2003. Microbiology (2007) 1.20
Mucosal vaccination and therapy with genetically modified lactic acid bacteria. Annu Rev Food Sci Technol (2011) 1.19
Lactococcus lactis expressing either Staphylococcus aureus fibronectin-binding protein A or Listeria monocytogenes internalin A can efficiently internalize and deliver DNA in human epithelial cells. Appl Environ Microbiol (2009) 1.19
Heterologous expression of BetL, a betaine uptake system, enhances the stress tolerance of Lactobacillus salivarius UCC118. Appl Environ Microbiol (2006) 1.17
Recombinant bacteriophage lysins as antibacterials. Bioeng Bugs (2011) 1.13
Probiotic lactic acid bacteria in the gastro-intestinal tract: health benefits, safety and mode of action. Benef Microbes (2010) 1.13
Identification and characterization of microcin S, a new antibacterial peptide produced by probiotic Escherichia coli G3/10. PLoS One (2012) 1.09
Reducing the carriage of foodborne pathogens in livestock and poultry. Poult Sci (2006) 1.07
Genetically engineered probiotics. Best Pract Res Clin Gastroenterol (2003) 1.03
Probiotics and gastrointestinal disease: successes, problems and future prospects. Gut Pathog (2009) 1.03
The economics of enteric infections: human foodborne disease costs. Gastroenterology (2009) 1.02
Designer probiotics for prevention of enteric infections. Nat Rev Microbiol (2006) 1.01
LAP, an alcohol acetaldehyde dehydrogenase enzyme in Listeria, promotes bacterial adhesion to enterocyte-like Caco-2 cells only in pathogenic species. Microbiology (2010) 1.01
Reduction of fecal shedding of enterohemorrhagic Escherichia coli O157:H7 in lambs by feeding microbial feed supplement. Small Rumin Res (2001) 1.00
Manufacturing process influences properties of probiotic bacteria. Br J Nutr (2010) 1.00
Toll-like receptor and innate cytokine responses induced by lactobacilli colonization and human rotavirus infection in gnotobiotic pigs. Vet Immunol Immunopathol (2008) 0.99
Expression of LAP, a SecA2-dependent secretory protein, is induced under anaerobic environment. Microbes Infect (2009) 0.98
Heat shock protein 60 acts as a receptor for the Listeria adhesion protein in Caco-2 cells. Infect Immun (2004) 0.96
Targeted expression of anthrax protective antigen by Lactobacillus gasseri as an anthrax vaccine. Future Microbiol (2010) 0.94
The dynamics of norovirus outbreak epidemics: recent insights. Int J Environ Res Public Health (2011) 0.92
Recombinant probiotic expressing Listeria adhesion protein attenuates Listeria monocytogenes virulence in vitro. PLoS One (2012) 0.92
Listeria monocytogenes uses Listeria adhesion protein (LAP) to promote bacterial transepithelial translocation and induces expression of LAP receptor Hsp60. Infect Immun (2010) 0.91
Inhibition of growth of Shiga toxin-producing Escherichia coli by nonpathogenic Escherichia coli. FEMS Microbiol Lett (2008) 0.91
Mice protected by oral immunization with Lactobacillus reuteri secreting fusion protein of Escherichia coli enterotoxin subunit protein. FEMS Immunol Med Microbiol (2007) 0.90
Adjuvant effects for oral immunization provided by recombinant Lactobacillus casei secreting biologically active murine interleukin-1{beta}. Clin Vaccine Immunol (2009) 0.89
Development of a chromosome-plasmid balanced lethal system for Lactobacillus acidophilus with thyA gene as selective marker. Microbiol Immunol (2000) 0.89
Probiotics and prebiotics to combat enteric infections and HIV in the developing world: a consensus report. Gut Microbes (2011) 0.89
Interaction of probiotics and pathogens--benefits to human health? Curr Opin Biotechnol (2010) 0.89
Construction and immunological evaluation of dual cell surface display of HIV-1 gag and Salmonella enterica serovar Typhimurium FliC in Lactobacillus acidophilus for vaccine delivery. Clin Vaccine Immunol (2012) 0.89
Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV. Vaccine (2009) 0.89
Battle of the bugs. Science (2008) 0.88
New insights into the impact of the intestinal microbiota on health and disease: a symposium report. Br J Nutr (2012) 0.88
Lactobacillus fermentum isolated from human colonic mucosal biopsy inhibits the growth and adhesion of enteric and foodborne pathogens. J Food Sci (2010) 0.88
Anti-infective mechanisms induced by a probiotic Lactobacillus strain against Salmonella enterica serovar Typhimurium infection. Int J Food Microbiol (2010) 0.88
New approaches to making the microenvironment of the female reproductive tract hostile to HIV. Am J Reprod Immunol (2011) 0.88
Designing probiotics with respect to the native microbiome. Future Microbiol (2012) 0.88
Surface display of N-terminally anchored invasin by Lactobacillus plantarum activates NF-κB in monocytes. Appl Environ Microbiol (2012) 0.88
Probiotic Lactobacillus casei expressing human lactoferrin elevates antibacterial activity in the gastrointestinal tract. Biometals (2010) 0.87
Engineering commensal bacteria for prophylaxis against infection. Curr Opin Biotechnol (2012) 0.87
Oral immunization with live Lactococcus lactis expressing rotavirus VP8 subunit induces specific immune response in mice. J Virol Methods (2011) 0.87
Use of VSL[sharp]3 in the treatment of rotavirus diarrhea in children: preliminary results. J Clin Gastroenterol (2008) 0.86
Nasal immunization of mice with Lactobacillus casei expressing the pneumococcal surface protein C primes the immune system and decreases pneumococcal nasopharyngeal colonization in mice. FEMS Immunol Med Microbiol (2011) 0.86
Lactobacillus plantarum AS1 binds to cultured human intestinal cell line HT-29 and inhibits cell attachment by enterovirulent bacterium Vibrio parahaemolyticus. Lett Appl Microbiol (2011) 0.86
Modern approaches in probiotics research to control foodborne pathogens. Adv Food Nutr Res (2012) 0.86
A Bifidobacterium-based synbiotic product to reduce the transmission of C. jejuni along the poultry food chain. Int J Food Microbiol (2012) 0.85
Novel natural food antimicrobials. Annu Rev Food Sci Technol (2012) 0.85
Evaluation of a Lactobacillus-based probiotic culture for the reduction of Salmonella enteritidis in neonatal broiler chicks. Poult Sci (2008) 0.85
Mucosal and systemic immune responses induced by recombinant Lactobacillus spp. expressing the hemagglutinin of the avian influenza virus H5N1. Clin Vaccine Immunol (2011) 0.84
Innate and acquired immune responses induced by recombinant Lactobacillus casei displaying flagellin-fusion antigen on the cell-surface. Vaccine (2010) 0.84
Intracellular accumulation of trehalose protects Lactococcus lactis from freeze-drying damage and bile toxicity and increases gastric acid resistance. Appl Environ Microbiol (2006) 0.84
Probiotic bacteria are antagonistic to Salmonella enterica and Campylobacter jejuni and influence host lymphocyte responses in human microbiota-associated immunodeficient and immunocompetent mice. Mol Nutr Food Res (2009) 0.84
Immunomodulating activity of Lactobacillus paracasei subsp. paracasei NTU 101 in enterohemorrhagic Escherichia coli O157H7-infected mice. J Agric Food Chem (2010) 0.83
Development of vaccine delivery vehicles based on lactic acid bacteria. Mol Biotechnol (2012) 0.82
A flagellin-producing Lactococcus strain: interactions with mucin and enteropathogens. FEMS Microbiol Lett (2011) 0.81
N-terminal Gly(224)-Gly(411) domain in Listeria adhesion protein interacts with host receptor Hsp60. PLoS One (2011) 0.81
Effect of lactic acid bacteria probiotic culture for the treatment of Salmonella enterica serovar Heidelberg in neonatal broiler chickens and turkey poults. Poult Sci (2011) 0.81
Biocontainment strategies for live lactic acid bacteria vaccine vectors. Bioeng Bugs (2011) 0.80
Norovirus as a foodborne disease hazard. Adv Food Nutr Res (2011) 0.80
Immunization of mice with Lactobacillus casei expressing intimin fragments produces antibodies able to inhibit the adhesion of enteropathogenic Escherichia coli to cultivated epithelial cells. FEMS Immunol Med Microbiol (2008) 0.79
Immunization with recombinant Lactobacillus casei strains producing K99, K88 fimbrial protein protects mice against enterotoxigenic Escherichia coli. Vaccine (2011) 0.79
Bacteriophages for detection and control of bacterial pathogens in food and food-processing environment. Adv Food Nutr Res (2012) 0.79
Lactobacillus acidophilus expressing recombinant K99 adhesive fimbriae has an inhibitory effect on adhesion of enterotoxigenic Escherichia coli. Microbiol Immunol (2005) 0.78
Protective effect of Lactobacillus casei strain Shirota against lethal infection with multi-drug resistant Salmonella enterica serovar Typhimurium DT104 in mice. J Appl Microbiol (2010) 0.78
Probiotics in the intensive care unit: why controversies and confusion abound. Crit Care (2008) 0.78
Prospects of photosensitization in control of pathogenic and harmful micro-organisms. J Appl Microbiol (2009) 0.78
Lactobacillus reuteri ATCC 55730 and L22 display probiotic potential in vitro and protect against Salmonella-induced pullorum disease in a chick model of infection. Res Vet Sci (2011) 0.77
Secretion of human interferon-beta 1b by recombinant Lactococcus lactis. Biotechnol Lett (2008) 0.76
Intragastric administration with recombinant Lactococcus lactis producing heme oxygenase-1 prevents lipopolysaccharide-induced endotoxemia in rats. FEMS Microbiol Lett (2008) 0.76
Indications and challenges of probiotics, prebiotics, and synbiotics in the management of arthralgias and spondyloarthropathies in inflammatory bowel disease. J Clin Gastroenterol (2008) 0.76